Owkin
Healthcare AI
Biopharma AI, drug discovery, clinical research, diagnostics
Series B
Owkin is a French-American AI healthcare and biotechnology company focused on agentic AI for biomedical research, biopharma decision-making, drug discovery, clinical research, and diagnostics. Its platform uses multimodal patient data and federated learning to help pharmaceutical and research organizations train models across distributed medical data without centralizing it.
Company Details
- Website
- owkin.com
- Headquarters
- New York, New York, United States
- Founded
- 2016
- Funding
- Over $304M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring